UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors

Cancer research (Chicago, Ill.), 2011-09, Vol.71 (18), p.6051-6060

2011

Volltextzugriff (PDF)

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

Cancer discovery, 2019-10, Vol.9 (10), p.1372-1387

2019

Volltextzugriff (PDF)

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Clinical cancer research, 2008-07, Vol.14 (13), p.4275-4283

2008

Volltextzugriff (PDF)

Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer

Cancer immunology research, 2016-04, Vol.4 (4), p.289-293

2016

Volltextzugriff (PDF)

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis

JCO precision oncology, 2020-11 (4), p.1098-1108

2020

Volltextzugriff (PDF)

Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes

Clinical cancer research, 2024-10

2024

Volltextzugriff (PDF)

A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer

Oncotarget, 2015-02, Vol.6 (6), p.4527-4536

2015

Volltextzugriff (PDF)

Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy

Radiotherapy and oncology, 2021-12, Vol.165, p.44-51

2021

Volltextzugriff (PDF)

Case report of tracheobronchial squamous cell carcinoma treated with radiation therapy and concurrent chemotherapy

Advances in radiation oncology, 2016-04, Vol.1 (2), p.127-131

2016

Volltextzugriff (PDF)

Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer

Clinical lung cancer, 2020-09, Vol.21 (5), p.455-463.e4

2020

Volltextzugriff (PDF)

Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study

Cancer nursing, 2013-03, Vol.36 (2), p.145-154

2013

Volltextzugriff (PDF)

Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Journal of thoracic oncology, 2010-11, Vol.5 (11), p.1855-1858

2010

Volltextzugriff (PDF)

Phase I/II investigator-initiated study of olaparib and temozolomide in SCLC: Updated analysis and CNS outcomes

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8565-8565

2022

Volltextzugriff (PDF)

The ASCENT trial: A phase II study of neoadjuvant afatinib, chemoradiation and surgery for stage III EGFR mutation-positive NSCLC

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.8544-8544

2018

Volltextzugriff (PDF)

Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.8571-8571

2018

Volltextzugriff (PDF)

Efficacy of Beclomethasone Nasal Solution, Flunisolide, and Cromolyn in Relieving Symptoms of Ragweed Allergy

Mayo Clinic proceedings, 1987-02, Vol.62 (2), p.125-134

1987

Volltextzugriff (PDF)

Episodic angioedema associated with eosinophilia

The New England journal of medicine, 1984-06, Vol.310 (25), p.1621-1626

1984

Volltextzugriff (PDF)

A phase II trial of erlotinib for EGFR mutant NSCLC to prospectively assess biopsy feasibility and acquired resistance at disease progression

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8076-8076

2015

Volltextzugriff (PDF)

Pulsed dosing of erlotinib for central nervous system (CNS) progression in EGFR-mutant non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8116-8116

2013

Volltextzugriff (PDF)

A pilot study of direct care nurse (DCN) education to improve adherence and knowledge of erlotinib in patients with non-small cell lung cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e19637-e19637

2012

Volltextzugriff (PDF)

Clinical characteristics of KRAS mutations in NSCLC and their impact on outcomes to first-line chemotherapy

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7588-7588

2012

Volltextzugriff (PDF)

Building-in ESD/EOS reliability for sub-halfmicron CMOS processes

IEEE transactions on electron devices, 1996-06, Vol.43 (6), p.991-999

1996

Volltextzugriff (PDF)

Hemolytic uremic syndrome associated with clopidogrel: a case report

Archives of internal medicine (1960), 2000-05, Vol.160 (9), p.1370

2000

Volltextzugriff (PDF)

P2-166: Full dose chemoradiation followed by surgical resection in locally advanced NSCLC

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S635-S635

2007

Volltextzugriff (PDF)

Endpoint detection in plasma etching

Journal of vacuum science & technology. A, Vacuum, surfaces, and films, 1985-05, Vol.3 (3), p.631-636

1985

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(89)
Französisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(35)
Humans
(33)
Male
(18)
Female
(17)
Middle Aged
(16)
Physical Sciences
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Adult
(12)
Aged
(11)
Chemistry
(11)
Chemistry, Organic
(10)
Oncology
(10)
Pharmacology. Drug Treatments
(9)
Lung Neoplasms - Drug Therapy
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(6)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular System & Cardiology
(5)
General & Internal Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis

Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes

A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer

Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy

Case report of tracheobronchial squamous cell carcinoma treated with radiation therapy and concurrent chemotherapy

Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer

Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study

Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Phase I/II investigator-initiated study of olaparib and temozolomide in SCLC: Updated analysis and CNS outcomes

The ASCENT trial: A phase II study of neoadjuvant afatinib, chemoradiation and surgery for stage III EGFR mutation-positive NSCLC

Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC)

Efficacy of Beclomethasone Nasal Solution, Flunisolide, and Cromolyn in Relieving Symptoms of Ragweed Allergy

Episodic angioedema associated with eosinophilia

A phase II trial of erlotinib for EGFR mutant NSCLC to prospectively assess biopsy feasibility and acquired resistance at disease progression

Pulsed dosing of erlotinib for central nervous system (CNS) progression in EGFR-mutant non-small cell lung cancer (NSCLC)

A pilot study of direct care nurse (DCN) education to improve adherence and knowledge of erlotinib in patients with non-small cell lung cancer

Clinical characteristics of KRAS mutations in NSCLC and their impact on outcomes to first-line chemotherapy

Building-in ESD/EOS reliability for sub-halfmicron CMOS processes

Hemolytic uremic syndrome associated with clopidogrel: a case report

P2-166: Full dose chemoradiation followed by surgical resection in locally advanced NSCLC

Endpoint detection in plasma etching

Suchergebnisse filtern